drugset / Trial / NCT03722433
Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication
RandomizedParallel-groupDouble-blindTreatment
Summary
The investigators aimed to assess the effect of probiotic supplementation with Vigiis 101-LAB during H. pylori eradication therapy with 14-day sequential therapy in the reduction of adverse effects and the restoration of the dysbiosis.
Timeline
- Start
- 2018-08-29
- Primary completion
- 2019-07-31
- Completion
- 2020-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vigiis 101-LAB | Other / unclassified | 1 unknown | — |
| Background | Amoxicillin | Other / unclassified | — | — |
| Background | Clarithromycin | Small molecule | — | — |
| Background | Esomeprazole | Small molecule | — | — |
| Background | Metronidazole | Small molecule | — | — |